凯赛生物授权子公司互保，额度不超20亿

Core Viewpoint - Shanghai Kaisa Biotechnology Co., Ltd. announced the authorization for its non-wholly-owned subsidiaries to provide guarantees for credit applications and daily operations, with a total guarantee limit not exceeding 2 billion yuan [1] Group 1 - The total amount of guarantees provided by non-wholly-owned subsidiaries as of the announcement date is 500 million yuan, all of which are inter-subsidiary guarantees [1] - The main entities being guaranteed include Kaisa (Taiyuan) Biomaterials Co., Ltd. and Kaisa (Taiyuan) Biotechnology Co., Ltd., both of which have a debt-to-asset ratio not exceeding 70% [1] - The authorization has been approved by the board of directors and does not require shareholder meeting approval, indicating that the guarantee risks are controllable and do not harm the interests of the company and its shareholders [1]